VANCOUVER, BRITISH COLUMBIA--(Marketwired - Dec. 4, 2013) - biOasis Technologies Inc. (TSX VENTURE:BTI) (the "Company") announces that, pursuant to the terms of its Stock Option Plan, the company has granted a total of 1,700,000 options to its officers, employees, consultants and members of the board of directors. 1,550,000 of the options are exercisable at a price of $0.97 per share until December 3, 2018 and 150,000 of the options are exercisable at a price of $0.97 per share until December 5, 2014. The options shall vest according to the Company's stock option plan.
On Behalf of the Board of Directors
Rob Hutchison, Chairman & CEO
"Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release"